Summary: Pregnane X receptor (PXR) mRNA was detected in HepG2 cells by RT-PCR, but not in human fetal liver (HFL) cells. CYP3A4 was induced by rifampicin (RIF), mifepristone (RU486), clotrimazole (CTZ), and dexamethasone (DEX) in HepG2 cells, while these PXR ligands with the exception of DEX did not induce CYP3A4 mRNA expression in HFL cells. Ad-PXR infection increased mRNA levels of PXR and CYP3A4 in both cells despite the absence of PXR ligands. Similar results were observed in reporter gene assays. However, in HFL cells, RIF-mediated CYP3A4 induction was insufficient compared with HepG2 cells, despite PXR overexpression. The expression levels of five coactivators (HNF4¡, PGC1¡, SRC1, CBP, and P300) related to CYP3A4 expression in HepG2, HFL cells, and human adult liver were analyzed by RT-PCR. Expression levels of HNF4¡ and PGC1¡ in HFL cells were downregulated to 20% of those in the human adult liver. On the other hand, the expression level of HNF4¡ in HepG2 cells was higher than that in HFL cells, although PGC1¡ expression level was almost the same as that in HFL cells. HNF4¡ mRNA expression level in HepG2 cells was 57% of that in human adult liver, and the level in HFL cells was 30% of that in HepG2 cells. These results suggested that lower expression of HNF4¡ and PGC1¡ may impair RIFmediated CYP3A4 induction under conditions of PXR overexpression in HFL cells.
Introduction
Cytochrome P450 ¤CYP¥ is a superfamily of heme proteins that play a critical role in the oxidative metabolism of endogenous and xenobiotic substances. 1¥ The human CYP3A subfamily includes four functional members, CYP3A4, CYP3A5, CYP3A7, and CYP3A43, which are expressed at different levels in the liver, kidney, and gastrointestinal tract.
2,3¥
CYP3A4 is the predominant isoform expressed in the adult human liver and was reported to be responsible for the metabolism of more than 60% of therapeutic drugs. 4,5¥ In contrast, CYP3A7 is the major CYP isoform in the human fetal liver. 6¥ CYP expression is modulated by a large variety of endogenous and exogenous substances, including drugs, and induction of CYP expression has been analyzed extensively in experimental animals. Toxicological and pharmacological studies designed to evaluate the safety and efficacy of candidate drugs and chemicals in the human fetus are largely dependent on extrapolation from animal models. However, it is difficult to estimate alterations of drug metabolism by inducers of drug-metabolizing enzymes in the human fetus due to the problems of differences among species.
7,8¥ Species differences in the inducibility of drug-metabolizing enzymes result in important differences in the metabolism of drugs and potential carcinogens. Therefore, primary cultures of hepatocytes and human hepatoma HepG2 cells have been widely used to study drug metabolism.
7,9¥ On the other hand, there have been few reports regarding the expression and induction of drug-metabolizing enzymes in human fetal hepatocytes in culture.
Previous studies of the induction of CYP3As by rifampicin ¤RIF¥ and glucocorticoids have elucidated a mechanism of regulation in which orphan nuclear receptors, such as the pregnane X receptor ¤PXR¥ and the constitutive androstane receptor ¤CAR¥ and steroid receptors, such as the glucocorticoid receptor ¤GR¥, play central roles in regulation of gene expression. 10®15¥ Upon ligand binding, PXR forms a heterodimer with retinoid X receptor AE ¤RXRAE¥ and transactivates ER-6 ¤everted repeat separated by six nucleotides¥ and DR-3 ¤direct repeat separated by three nucleotides¥ elements upstream of CYP3A4. 16®20¥ We reported previously that CYP3A4 and CY3A7 mRNA expression levels were markedly upregulated by dexamethasone ¤DEX¥, but not by RIF, in human fetal liver ¤HFL¥ cells. We considered that CYP3A4 and CYP3A7 mRNA expression were not induced by RIF because PXR expression level was very low or absent in HFL cells.
11,21¥
Recently, some transcription factors ¤coactivators and corepressors¥ that mediate CYP3As expression have been reported. Hepatocyte nuclear factor 4AE ¤HNF4AE¥ is one of the most important liver-enriched transcription factors for hepatocyte differentiation.
22¥ HNF4AE plays critical roles not only in specification of the hepatic phenotype during liver development but also in the transcriptional regulation of genes involved in glucose, cholesterol, fatty acid, and xenobiotic metabolism and in the synthesis of blood coagulation factors.
23,24¥ Peroxisome proliferator-activated receptor È coactivator 1AE ¤PGC1AE¥ is a key metabolic regulator and was originally identified as a peroxisome proliferatoractivated receptor È interacting coactivator in brown adipose tissue. 25¥ Recent studies showed that PGC1AE is a versatile coactivator for numerous nuclear receptors and has been implicated in diverse biological activities, including lipid and carbohydrate metabolism.
26,27¥ PGC1AE has been shown to increase the HNF4AE-mediated transactivation of CYP7A1, phosphoenolpyruvate carboxykinase ¤PEPCK¥, and glucose-6-phosphatase genes.
27®29¥ PXR promotes CYP3A4 gene transcription by interacting with HNF4AE, steroid receptor coactivator 1 ¤SRC1¥, and PGC1AE. Moreover, RIF strongly stimulates PXR and HNF4AE interaction and CYP3A4 promoter activity, which are further enhanced by PGC1AE and SRC1 but inhibited by the small heterodimer partner ¤SHP¥.
13,30¥
In the present study, we investigated the effects of PXR overexpression on drug-mediated induction of CYP3As mRNA expression in HFL cells and the expression levels of other transcription factors that were reported to be related to CYP3As expression. Cell culture and adenovirus infection: HepG2 and HFL cells were seeded onto dishes coated with collagen ¤type I¥ and cultured in Dulbeccoös modified Eagleös medium and Williamsö medium E, respectively, supplemented with 10% FBS, 2 mM glutamine, and antibiotics ¤50 µg/ml penicillin, 50 µg/ml streptomycin, and 100 µg/ml neomycin¥ under an atmosphere of 5% CO 2 in air at 37ôC. The medium was replaced every 24 h. The recombinant adenoviruses, Ad-lacZ, Ad-PXR, and Ad-CYP3A4-362-7.7k-Luc, were provided by Yamazoe and Nagata. HepG2 and HFL cells were subcultured for 3 or 7 days after seeding of 4 ' 10 4 cells onto 6-or 24-well culture plates. When subculture was performed, the cells were infected with Ad-lacZ ¤50 MOI¥, Ad-PXR ¤50 MOI¥, and Ad-CYP3A4-362-7.7k-Luc ¤25 MOI¥ solution for 1 h. In the drug treatment groups, HepG2 and HFL cells were treated with DEX ¤100 µM¥, RIF ¤40 µM¥, RU486 ¤10 µM¥, and CTZ ¤10 µM¥ for 48 h. The above compounds were dissolved in DMSO ¤vehicle¥, which was added to the culture medium at a final concentration of 0.1%. The medium was replaced daily with fresh medium containing either the test compounds dissolved in vehicle or vehicle alone. After treatment with the test compounds for 48 h, the cells were harvested using the cell lysis solution for RT-PCR and reporter gene assays.
Materials and Methods

Materials
RNA extraction and reverse transcription reaction: Total RNA was extracted using an illustra RNAspin Mini RNA Isolation Kit according to the manufacturerös instructions. First-strand cDNA was generated from 1®2 µg of total RNA. Reverse transcription reaction was performed using a SuperScript III First-Strand Synthesis System for RT-PCR in accordance with the manufacturerös instructions.
Semiquantitative RT-PCR:
The mRNA expression levels of nuclear receptors, transcription factors, and target genes of HNF4AE and PGC1AE were analyzed by semiquantitative RT-PCR. PCR was carried out with the cDNAs thus obtained using a MyCycler thermal cycler ¤Bio-Rad, Hercules, CA¥ and PCR Express thermal cycler ¤Hybaid Ltd., Teddington, Middlesex, UK¥. The primers and amplification conditions used are summarized in Table 1 . The levels of these mRNAs were quantified from their band densities on agarose gels using Printgraph AE-6914 and Scion Image Software ¤by W. Rasband¥, and were normalized relative to glyceraldehyde-3-phosphate dehydrogenase ¤GAPDH¥ mRNA.
Real-time RT-PCR analysis: CYP3As mRNA expression levels were analyzed by SYBR Green realtime RT-PCR. PCR was carried out with the cDNAs thus obtained using an ABI 7300 Real-Time PCR System ¤Applied Biosystems, Foster City, CA¥ according to the manufacturerös instructions. The primers and amplification conditions used are summarized in Table 2 . The levels of these mRNAs were normalized relative to that of GAPDH mRNA.
Reporter gene assay: Reporter gene assay was performed according to the manufacturerös instructions using a Sirius Luminometer ¤Berthold Japan, Tokyo, Japan¥. CYP3As mRNA expression levels in HepG2 and HFL cells: RIF is a highly effective inducer of CYP3A enzymes in adult human liver cells in primary culture. 1¥ Here, we evaluated the effects of PXR ligands including RIF on CYP3A4, CYP3A5, and CYP3A7 mRNA expression in HepG2 and HFL cells by real-time RT-PCR. CYP3A4, 
CYP3A5
, and CYP3A7 mRNA expression levels in HepG2 cells were increased from 6-to 11-fold by RIF ¤Fig. 2¥. The other PXR ligands, RU486, CTZ, and DEX, induced an increase in CYP3A4, CYP3A5, and CYP3A7 mRNA expression by 3-to 7.4-fold in HepG2 cells. In contrast, RIF, RU486, and CTZ did not appreciably induce CYP3A4, CYP3A5, or CYP3A7 mRNA expression in HFL cells, although the expression levels of CYP3A4, CYP3A5, and CYP3A7 were increased to 3.4-, 2.3-, and 2.2-fold, respectively, by DEX. Next, we examined the effects of PXR overexpression on PXR ligand-mediated CYP3As mRNA expression. Adenovirus-mediated transfection of PXR caused significant increases in CYP3A4, CYP3A5, and CYP3A7 mRNA expres- sion in HepG2 and HFL cells without PXR ligands ¤Fig. 2¥. Under conditions of PXR overexpression, PXR ligandmediated CYP3A4, CYP3A5, and CYP3A7 mRNA expression levels were increased to a greater extent than in HepG2 cells uninfected with Ad-PXR. Regardless of PXR overexpression in HFL cells, PXR ligands except DEX did not appreciably induce expression of CYP3A4, CYP3A5, or CYP3A7 mRNAs compared to HepG2 cells ¤Fig. 2¥.
CYP3A4 promoter activity in HepG2 and HFL cells:
We used a luciferase promoter construct ¤Ad-CYP3A4-362-7.7k-Luc¥ to investigate the effects of PXRmediated transactivation and PXR ligands on CYP3A4 promoter activity in HFL cells. Ad-CYP3A4-362-7.7k-Luc construct contained the core promoter ¤%362/¦11¥ and the enhancer region ¤%7.2k/%7.8k¥ including ER-6 and DR-3 motifs.
CYP3A4 transactivation was detected without overexpression of PXR in HepG2 cells by PXR ligands, while no transactivation was detected in HFL cells ¤Fig. 3¥. Overexpression of PXR enhanced the transactivation in HepG2 and HFL cells. The activity was also increased to a greater extent by PXR ligands ¤RIF, RU486, and CTZ¥ in HepG2 cells. However, appreciable RIF-induced transactivation was not observed in HFL cells, even after overexpression of PXR. Similarly, other PXR ligands except CTZ did not show sufficient transactivation in HFL cells. However, CTZ significantly increased CYP3A4 transactivation after overexpression of PXR in HFL cells ¤7.2-fold, p g 0.01¥ ¤Fig. 3¥.
Transcription factor expression levels in HFL cells:
We measured the expression levels of five coactivators in HepG2 and HFL cells and in human adult liver by RT-PCR. The expression levels of HNF4AE and PGC1AE mRNAs in HFL cells were about 20% of those in human adult liver. The expression level of PGC1AE mRNA in HepG2 cells was similar to that in HFL cells. On the other hand, HNF4AE mRNA level in HepG2 cells was 57% of that in human adult liver. The expression levels of CBP and P300 were 60®70% of those in the human adult liver, while SRC1 mRNA expression level in HFL cells was higher than those in HepG2 cells and human adult liver ¤1.3-fold¥ ¤Fig. 4¥. We also examined the expression of three corepressors, SMRT, NCoR1, and SHP. The expression levels of SMRT and NCoR1 in HFL cells were similar to those in HepG2 cells and 70®90% of those in human adult liver. SHP mRNA expression was not detected in HFL cells ¤Fig. 4¥. Ad-PXR infection did not affect mRNA levels of the above coactivators or corepressors in HepG2 or HFL cells ¤data not shown¥.
HNF4AE and PGC1AE target gene expression in HFL cells: To confirm the functions of HNF4AE and PGC1AE in HFL cells, we examined mRNA expression levels of ApoCIII and PEPCK, which are target genes of HNF4AE and PGC1AE. ApoCIII mRNA was detected in HepG2 cells, although the expression level was about 10% of that in human adult liver. On the other hand, ApoCIII mRNA was not detected in HFL cells under the present analytical conditions. PEPCK mRNA was not detected in HFL or HepG2 cells ¤Fig. 5¥.
Discussion
CYP3As gene expression is modulated by a large variety of endogenous and exogenous substances, including drugs, and induction of CYP3As expression has been analyzed extensively using experimental animals. However, it has been difficult to estimate alterations in drug metabolism by inducers of drug-metabolizing enzymes in the human fetus due to the problems of differences among species. Recently, primary cultures of human hepatocytes, HepG2 and HepaRG cells, have been used to study drug metabolism and enzyme induction. On the other hand, there have been few reports regarding the expression and induction of drugmetabolizing enzymes in human fetal hepatocytes in culture. After treatment, CYP3A4 promoter activity was analyzed by luciferase gene assay as described in Materials and Methods. Data are presented as the ratios of CYP3A4 promoter activity as relative light units (RLU)/mg to protein and normalized at 1.0 for Ad-lacZ infection and DMSO treatment alone. Columns and vertical bars represent means and SD (n ¦ 4 -6). Significantly different from DMSO group (*p g 0.05, **p g 0.01, ***p g 0.001).
We reported previously that CYP3A4 and CY3A7 mRNA expression levels were markedly upregulated by DEX in HFL cells.
11, 21¥ We showed that GR plays a critical role in DEX-mediated CYP3As induction in HFL cells. However, RIF-mediated CYP3As induction was not observed, and PXR mRNA was not detected in HFL cells by RT-PCR. 11¥ We considered that the very low level or absence of PXR expression may impair RIF-mediated CYP3As induction.
Upon ligand binding, PXR forms a heterodimer with RXRAE and transactivates ER-6 and DR-3 regions upstream of CYP3A4. Takada et al. performed reporter gene assays in HepG2 cells using a CYP3A4-luciferase fusion vector ¤pCYP3A4-362-7.7k¥ containing ER-6 and DR-3 regions and concluded that these regions were important in PXRmediated CYP3A4 transactivation. Furthermore, they described the possibility of another cis-element mediating the basal transactivation by PXR in addition to ER-6 and DR-3 regions. 20¥ Accordingly, PXR and RXRAE are essential for PXR ligand-mediated CYP3A4 induction. RXRAE expression was confirmed in HFL cells, but PXR was not detected ¤Fig. 1¥. The present study was performed to examine the effects of PXR overexpression on PXR ligand-mediated CYP3As induction in HFL cells. The HepG2 cell line was established from a liver tumor biopsy specimen from a 15-year-old white male subject. 31¥ The induction of CYP in HepG2 cells has been studied as a model of human liver.
32,33¥
This cell line, however, has features of hepatoblast-like cells, because the cells express CYP3A7 34¥ and secrete AFP 31¥ into the cell culture medium, both proteins that are found predominantly in human fetal hepatocytes. 35¥ PXR mRNA was not detectable in HFL cells, although it was expressed in HepG2 cells. PXR has been identified as the major receptor responsible for transcriptional activation of CYP3A gene expression. 36¥ Another cellular factor, GRAE, 37,38¥ is known to influence xenobiotic-mediated transcription induction, through cooperative activation of PXR expression. The level of GRAE mRNA expression was almost identical in HepG2 and HFL cells. These CYP enzymes in HFL cells were significantly induced by DEX. We suggested previously that one reason why CYP3A4 and CYP3A7 mRNA expression were not induced by RIF in HFL cells may be that PXR expression level is very low in these cells as compared with HepG2 cells. 11¥ In this study, we used HepG2 cells as a positive control for HFL cells.
PXR overexpression, without PXR ligands, caused increases in CYP3As expression in HepG2 and HFL cells ¤Fig. 2¥. Similar results were observed in the reporter gene assays ¤Fig. 3¥. Support for this observation was provided in a report by Zang et al. 39¥ These results indicated that PXR plays an important role in basal CYP3As expression. RIF, RU486, CTZ, and DEX are known to be PXR ligands. These ligands caused the induction of CYP3As with or without PXR overexpression in HepG2 cells ¤Figs. 2 and 3¥ and the expression levels were further increased by PXR overexpression in HepG2 cells ¤Figs. 2 and 3¥.
Previously, we suggested that PXR underexpression impaired RIF-mediated CYP3A4 induction in HFL cells. However, these results suggested that factors other than PXR underexpression may control RIF-mediated CYP3A4 induction in HFL cells. DEX, which is known to be a GR ligand, increased CYP3As mRNA expression, unrelated to PXR overexpression. Interestingly, in HFL cells CTZ-mediated CYP3A4 induction was not detected by RT-PCR ¤Fig. 2¥, while CTZ markedly increased CYP3A4 transactivation under conditions where PXR was overexpressed ¤Fig. 3¥. In addition, CTZ-mediated CYP3A4 induction was lower than that induced by RIF in HepG2 cells ¤Fig. 2¥. Furukawa et al. reported that CTZ strongly activated CYP3A4 promoter activity while RIF did not in HepG2 cells using a CYP3A4-luciferase reporter construct ¤%362/¦11¥. 40¥ These results indicated that the mechanisms of RIF-and CTZ-mediated CYP3A4 induction may be different.
Recently, transcription factors that mediate CYP3As expression have been identified. Various studies have shown that HNF4AE interacts strongly with the p160 family coactivators ¤SRC1, 2, and 3¥ and that HNF4AE activity is enhanced by the action of CBP/P300. 41®45¥ On the other hand, SHP has been shown to decrease PXR-mediated transactivation and another corepressor-silencing mediator of retinoic acid and thyroid hormone receptor ¤SMRT¥, nuclear receptor corepressor 1 ¤NCoR1¥, inhibits PXR transactivation. 13,30,46¥ HNF4AE is one of the most important liver-enriched transcription factors involved in hepatocyte differentiation. HNF4AE increases PXR-mediated CYP3A4, CYP2C8, and CYP2C9 transactivation.
47®50¥ Furthermore, PGC1AE has been shown to increase the HNF4AE-mediated transactivation of CYP7A1, PEPCK, and glucose-6-phosphatase genes.
27®29¥
Interaction with PXR, HNF4AE, SRC1, and PGC1AE has been shown to enhance RIF-mediated CYP3A4 transactivation in HepG2 cells. 50¥ Martinez-Jiménez et al. demonstrated that in HepG2 cells, PGC1AE and SRC1 expression levels were lower to allow maximal function of HNF4AE. HNF4AE was expressed at levels as high as in human liver but its activity on target genes ¤ApoCIII, ApoAV, PEPCK, AldoB, OTC, and CYP7A1¥ was very low or absent in HepG2 cells. They concluded that PGC1AE and SRC1 are key coactivators for the proper function of HNF4AE. 51¥ We found similar results in HepG2 cells, in that PGC1AE and SRC1 expression levels were 20 ® 25% of those in the human adult liver ¤Fig. 4¥. HNF4AE mRNA was detected in both HepG2 and HFL cells, but its expression level was lower in HFL cells than in HepG2 cells ¤Fig. 4¥. PGC1AE mRNA expression level in HFL cells was similar to that in HepG2 cells, but lower than that in the human adult liver ¤Fig. 4¥. Corepressor SMRT and NCoR1 mRNA expression levels in HFL cells were similar to those in HepG2 cells, but SHP was not detectable in HFL cells ¤Fig. 4¥. These results suggested that lower levels of HNF4AE and PGC1AE expression may impair RIF-mediated CYP3A4 induction under conditions where PXR is overexpressed in HFL cells. The expression levels of the HNF4AE target genes ApoCIII and PEPCK are indirectly enhanced by PGC1AE, 26,27,52,53¥ and ApoCIII and PEPCK mRNA expression levels were very low or below the limit of detection in HepG2 cells ¤Fig. 5¥. Similarly, neither ApoCIII nor PEPCK mRNA expression was detected in HFL cells ¤Fig. 5¥. These results suggested that low levels of HNF4AE and PGC1AE expression may impair HNF4AE target gene expression in HFL cells.
The PXR promoter has been reported to contain the HNF4AE binding site that is required for expression of PXR in fetal hepatocytes. Further, HNF4AE regulates the expression of xenobiotic-related PXR target genes through control of PXR in fetal liver development. 49¥ These reports suggested that HNF4AE is important for the expression of PXR and PXR target genes. The above results suggested that low levels of HNF4AE and PGC1AE expression may be responsible for PXR dysfunction as RIF-mediated CYP3As induction was insufficient in HFL cells compared with HepG2 cells.
